204 related articles for article (PubMed ID: 37001272)
1. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L
J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272
[TBL] [Abstract][Full Text] [Related]
2. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Wang W; Cui G; Zhao S
Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
Front Immunol; 2022; 13():986447. PubMed ID: 36544782
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analyses of a CD8
Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Th1 cells in lung squamous cell carcinoma.
Wang J; Zhou J; Zhou Q; Qi Y; Zhang P; Yan C; Ren X
J Leukoc Biol; 2022 Dec; 112(6):1567-1576. PubMed ID: 35686499
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
Diao X; Guo C; Liu L; Wang G; Li S
Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
[TBL] [Abstract][Full Text] [Related]
8. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma.
Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M
Front Oncol; 2022; 12():933925. PubMed ID: 35912252
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis.
Shi H; Lei S; Xiong L; Du S; Shi Y
Arch Biochem Biophys; 2024 Jan; 751():109842. PubMed ID: 38040224
[TBL] [Abstract][Full Text] [Related]
11. Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.
Yang M; Lin C; Wang Y; Chen K; Zhang H; Li W
Genome Med; 2022 Jul; 14(1):72. PubMed ID: 35799269
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.
Wang XJ; Chen JP; Qiao XW; Meng WY; Wang YW; Meng YC; Zhao R; Lin W; Liao YD; Xiao H; Mei PY
Curr Med Sci; 2024 Apr; 44(2):309-327. PubMed ID: 38517673
[TBL] [Abstract][Full Text] [Related]
13. Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma.
Feng Y; Xiong X; Wang Y; Han D; Zeng C; Mao H
Lung; 2022 Jun; 200(3):381-392. PubMed ID: 35511293
[TBL] [Abstract][Full Text] [Related]
14. Classification of the immune microenvironment associated with 12 cell death modes and construction of a prognostic model for squamous cell lung cancer.
Bin Y; Ding P; Liu L; Tong F; Dong X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9051-9070. PubMed ID: 37169931
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma.
Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S
Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.
Tian H; Wei R; Xiao C; Fan T; Che Y; Liu T; Zheng B; Li C; He J
BMC Pulm Med; 2024 Jan; 24(1):53. PubMed ID: 38273291
[TBL] [Abstract][Full Text] [Related]
17. MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma.
Zhang W; Li GS; Gan XY; Huang ZG; He RQ; Huang H; Li DM; Tang YL; Tang D; Zou W; Liu J; Dang YW; Chen G; Zhou HF; Kong JL; Lu HP
PeerJ; 2023; 11():e15598. PubMed ID: 37601247
[TBL] [Abstract][Full Text] [Related]
18. Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma.
Lu J; Duan Y; Liu P; He X; Yang Y; Zhang R; Weng L
J Pathol; 2023 Jan; 259(1):21-34. PubMed ID: 36178315
[TBL] [Abstract][Full Text] [Related]
19. Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma.
Chen M; Ma P; Zhang Y; Wang D; Yu Z; Fu Y; Zhao X; Wang M; Zhuang G; Jing Y
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857527
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway.
Zou W; Wang X; Xia X; Zhang T; Nie M; Xiong J; Fang X
Biochem Biophys Res Commun; 2024 Jan; 692():149338. PubMed ID: 38043156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
